Xenon Pharmaceuticals Priced, Nasdaq: XENE

Licenses drugs to uniQure, Teva and Genentech for LPLD, pain and acne.

Industry: Health Care

Latest Trade: $4.55 0.00 (0.0%)

First Day Return: +16.7%

Return from IPO: -49.4%

Industry: Health Care

Licenses drugs to uniQure, Teva and Genentech for LPLD, pain and acne.
more less
IPO News for Xenon Pharmaceuticals
more
IPO Data
IPO File Date 09/10/2014
Offer Price $9.00
Price Range $10.00 - $12.00
Offer Shares (mm) 4.0
Deal Size ($mm) $36
IPO Data
IPO Date 11/04/2014
Offer Price $9.00
Price Range $10.00 - $12.00
Offer Shares (mm) 4.0
Deal Size ($mm) $36
Underwriters
more
Company Data
Headquarters Burnaby, Canada
Founded 1996
Employees 74
Website www.xenon-pharma.com